Psychiatry

Borderline Personality Disorder – The difficult patient

Borderline Personality Disorder – The difficult patient – MM1602

GPs are often the first point of contact for patients with borderline personality disorder (BPD) and this encounter can be critical in engaging these patients with health services that can provide support and treatment.

BPD is a mental disorder and a personality disorder according to the Diagnostic and Statistical Manual of Mental Disorders(5) and is characterised by distressing emotional states, difficulty relating to other people and self-harming behaviour. Common presentations include visits to emergency departments with self-harm, or seeing their GPs with suicidality, low mood or treatment-resistant depression.

Modern Medicine – February 2016

The Ups and Downs of Bipolar Disorder in General Practice

The Ups and Downs of Bipolar Disorder in General Practice – MM1508

GPs are uniquely placed to identify patients with bipolar disorder and to contribute to their management, including addressing physical health problems and encouraging a stable balanced life and sleep/wake cycle. Treatment is generally with mood stabilisers rather than antidepressants, in collaboration with a psychiatrist.

Modern Medicine – August 2015

Cognitive Impairment Persists after Depressive Episodes

Cognitive Impairment Persists after Depressive Episodes – MM1507

Cognitive dysfunction is a core component of major psychiatric disorders, such as major depressive disorder (MDD), schizophrenia and bipolar disorder (BD). Although it was initially thought that cognitive impairments in MDD were state-related, increasing evidence suggests that cognitive abnormalities persist beyond depressive episodes.

Modern Medicine – July 2015

Improving Positive Affect in a Practical Manner

Improving Positive Affect in a Practical Manner – MM1507

Over the years positive psychology has placed strong emphasis on how positive affect can improve health. This prompted Vista Clinic to develop the Happiness HELPS campaign as a means of improving positive affect in patients. The aim of the campaign is to promote mental health and to reduce the symptoms of depression. The Happiness HELPS concept consists of a set of practical actions that can be carried out on a daily basis in order to combat the negative emotional affects of depression and anxiety. The acronym “HELPS” provides an easy-to-follow guide which can be used by everyone to promote and maintain their mental health.
HELPS stands for:
• Help Others
• Exercise
• Learn
• Play
• Spiritual Growth

Modern Medicine – July 2015

The Treatment of Schizophrenia An Overlooked ‘Duty to Care’

The Treatment of Schizophrenia An Overlooked ‘Duty to Care’ – MM1506

Schizophrenia remains a challenging illness causing high levels of chronic disability. Identifying the condition early is difficult, medication adherence is problematic, the availability of psychosocial interventions is limited and the poor physical health of people with schizophrenia is often overlooked.

Modern Medicine – June 2015

Detecting and Managing Depression in Patients with Cardiac Disease

Detecting and Managing Depression in Patients with Cardiac Disease – MM1503

Depression is common in patients with cardiac disease, is associated with increased risk of mortality and morbidity and is the major driver of quality of life. Depression is also a major determinant of adherence to treatment strategies. It is therefore important that depressive symptoms are recognised and treated early in patients with cardiac disease.

Modern Medicine – March 2015

Lamotrigine is an Antiepileptic and Mood Stabiliser

Lamotrigine is an Antiepileptic and Mood Stabiliser – MM1503

Lamotrigine is used in combination with other anti-seizure drugs for the treatment of partial seizures, tonicclonic seizures and seizures of Lennox-Gastaut syndrome. It is also used alone for treating partial seizures in patients 16 years and older when converting from other anti-epileptic drugs. Lamotrigine also is used for preventing mood episodes in individuals 18 years or older with bipolar disorder.

Modern Medicine – March 2015

Omega-3 Fatty Acids for Managing Mood Disorders

Omega-3 Fatty Acids for Managing Mood Disorders – MM1501

A decade ago research indicated a likely causal link between low levels of omega-3 fatty acids (FAs) and a higher prevalence of mood disorders, and also provided quite strong support for omega-3 FAs as both an antidepressant monotherapy and an augmentor of formal antidepressant drugs. Recent research is somewhat less convincing about their antidepressant efficacy but is nevertheless furthering our understanding by quantifying differential efficacy across the FAs.

Modern Medicine – January 2015

Verified by ExactMetrics